TY - JOUR
T1 - Intravitreous Injection of Adenosine or Its Agonists Causes Breakdown of the Blood-Retinal Barrier
AU - Sen, Harsha A.
AU - Campochiaro, Peter A.
PY - 1989/9
Y1 - 1989/9
N2 - Pigmented rabbits were anesthetized and given an intravitreous injection of 0.1 mL of a test substance or vehicle alone. Vitreous fluorophotometry was performed before injections and at various time points after injections. Compared with pretreatment scans, vehicleinjected eyes showed no change in intravitreous fluorescein sodium leakage at 6 and 24 hours after injection. Injection of adenosine (10-2 mol/L) resulted in fluorescein leakage that was significantly greater than that which occurred in control eyes at 6 hours after injection, but returned to baseline at 24 hours. This effect was significantly attenuated by an adenosine receptor antagonist (BWA1433U), suggesting that it was mediated by specific adenosine receptors. A nonselective adenosine receptor agonist, N-ethylcarboxamidoadenosine, and two relatively A1 selective receptor agonists, N6-cyclopentyladenosine and N6-phenylisopropyladenosine, also caused dosedependent intravitreous fluorescein leakage. The relative order of potency was N-ethylcarboxamidoadenosine much greater than N6-phenylisopropyladenosine, which was greater than N6-cyclopentyladenosine, implicating A2 adenosine receptors. Intravitreous injection of dipyridamole, an adenosine uptake inhibitor, caused enhanced fluorescein leakage, presumably from extracellular accumulation of endogenous adenosine. The results of this study suggest that adenosine may be a mediator of blood-retinal barrier breakdown.
AB - Pigmented rabbits were anesthetized and given an intravitreous injection of 0.1 mL of a test substance or vehicle alone. Vitreous fluorophotometry was performed before injections and at various time points after injections. Compared with pretreatment scans, vehicleinjected eyes showed no change in intravitreous fluorescein sodium leakage at 6 and 24 hours after injection. Injection of adenosine (10-2 mol/L) resulted in fluorescein leakage that was significantly greater than that which occurred in control eyes at 6 hours after injection, but returned to baseline at 24 hours. This effect was significantly attenuated by an adenosine receptor antagonist (BWA1433U), suggesting that it was mediated by specific adenosine receptors. A nonselective adenosine receptor agonist, N-ethylcarboxamidoadenosine, and two relatively A1 selective receptor agonists, N6-cyclopentyladenosine and N6-phenylisopropyladenosine, also caused dosedependent intravitreous fluorescein leakage. The relative order of potency was N-ethylcarboxamidoadenosine much greater than N6-phenylisopropyladenosine, which was greater than N6-cyclopentyladenosine, implicating A2 adenosine receptors. Intravitreous injection of dipyridamole, an adenosine uptake inhibitor, caused enhanced fluorescein leakage, presumably from extracellular accumulation of endogenous adenosine. The results of this study suggest that adenosine may be a mediator of blood-retinal barrier breakdown.
UR - http://www.scopus.com/inward/record.url?scp=0024435401&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024435401&partnerID=8YFLogxK
U2 - 10.1001/archopht.1989.01070020434049
DO - 10.1001/archopht.1989.01070020434049
M3 - Article
C2 - 2783068
AN - SCOPUS:0024435401
SN - 0003-9950
VL - 107
SP - 1364
EP - 1367
JO - Archives of ophthalmology
JF - Archives of ophthalmology
IS - 9
ER -